ISARIC Virtual Assembly meeting agenda
Wednesday 17 November 2021
Opening session – A Global Clinical Research Network for Global Health Security
12:00 – 12:15 GMT | Welcome | 15’ | Roberto Bruzzone, Chair |
12:15 – 12:20 GMT | Keynote speaker | 5’ | Mike Ryan, Executive Director, WHO Health Emergencies Programme |
12:20 – 12:45 GMT | The need for global clinical research capability – ISARIC as a foundation network | 25’ | Peter Horby, Executive Director |
Session 2 – A Sustainable Clinical Surveillance and Analysis Network
Chairs: Yaseen Arabi and Armand Sprecher
12:50 – 12:55 GMT | Introduction | 5’ | Chairs |
12:55 – 13:10 GMT | How the observational studies platform evolved in the context of COVID-19 | 15’ | Alistair Nichol, ICC-CTN |
13:10 – 13:25 GMT | Aggregating and analysing international data, partner analyses | 15’ | Felipe Reyes, LIVEN |
13:25 – 13:40 GMT | Supporting research networks | 15’ | Waasila Jassat, NICD |
13:40 – 13:45 GMT | Break | ||
13:45 – 14:00 GMT | Integrating clinical research platforms into pandemic and epidemic intelligence | 15’ | Oliver Morgan, Director, Health Emergency Information and Risk Assessment, WHO Health Emergencies Programme |
14:00 – 14:15 GMT | Future plans for outbreak research designs | 15’ | Srinivas Murthy, Board Member |
14:15 – 14:30 GMT | Technical innovations and future plans | 15’ | Laura Merson, Head of Data |
14:30 – 15:00 GMT | Panel discussion and Q&A | 30’ | Chairs |
15:00 GMT | End of Day One |
Thursday 18 November 2021
Session 3 – Strengthened Global Clinical Trials Architecture
Chairs: Gail Carson and Lina Moses
12:00 – 12:05 GMT | Introduction | 5’ | Gail Carson, Director of Network Development |
12:05 – 12:45 GMT | ISARIC Regional Hubs: strengthening local clinical trials capacity | 40’ |
Madiha Hashmi, SEARCH Muge Cevik, EDCTP SimpliciTB COVID19 Consortium &
Janice Caoili, TDF |
12:45 – 13:00 GMT | Building baseline data for improved clinical research, trials and best practice | 15’ |
ISARIC Fellows – Joseph Bonney, Paa Kobina Forson, Moses Siaw-Frimpong |
13:00 – 13:10 GMT
13:10 – 13:30 GMT |
Keynote speaker
Panel discussion |
10′
|
Jeremy Farrar, Director of Wellcome
Speakers, Muge Cevik, EDCTP SimpliciTB, Lina Moses, GOARN & Kenny Baillie, GenOMICC
|
Session 4 – Research Studies and Co-designed Clinical Development Plans
Chairs: Piero Olliaro and Adebola Olayinke
13:30 – 13:40 GMT | Introduction | 10’ | Piero Olliaro, Director of Science |
13:40 – 14:00 GMT | Navigating the challenges of competing epidemics in a randomised controlled trial: a case study of bubonic plague | 20’ | Rindra Randremanana, IPM Mihaja Raberahona, CICM |
14:00 – 14:15 GMT | An alternative approach to generating clinical evidence for novel therapeutics when traditional trial designs are not feasible: the use of an expanded access programme for monkeypox | 15’ | Emmanuel Nakouné, IPB |
14:15 – 14:45 GMT | Co-designed clinical development plans: the West Africa Lassa fever Consortium | 30’ | Piero Olliaro, Director of Science Adebola Olayinke, NCDC |
14:45 – 15:00 GMT | Summary and Q&A | 15’ | Piero Olliaro, Director of Science |
15:10 – 15:25 GMT | Recap and voting | 15’ | Peter Horby, Executive Director |
15:25 – 15:30 GMT | Closing remarks | 5’ | Roberto Bruzzone, Chair |
15:30 | Member Assembly closed |
ISARIC Zoom background (right-click with mouse and select “Save image to downloads“)